Your browser doesn't support javascript.
loading
Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report.
Almarhabi, Hassan; Alharbi, Aisha; Alalawi, Mai; Ahamed, Mohamed Firoze; El-Hemaidi, Ihab; Damfu, Nader.
Affiliation
  • Almarhabi H; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
  • Alharbi A; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Pharmaceutical Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia. Electronic address: aalharbi0755@gmail.com.
  • Alalawi M; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Pharmaceutical Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Ahamed MF; Consultant Radiologist, Medical Imaging Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • El-Hemaidi I; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Consultant Adult Hematology/BMT, Princess Norah Oncology Center, Jeddah, Saudi Arabia.
  • Damfu N; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Infection Prevention and Control Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNGHA), Jeddah, Saudi Arabia.
J Infect Public Health ; 17(10): 102526, 2024 Oct.
Article in En | MEDLINE | ID: mdl-39226796
ABSTRACT
Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ritonavir / COVID-19 / COVID-19 Drug Treatment Limits: Adult / Humans / Male Language: En Journal: J Infect Public Health / J. infect. public health / Journal infection and public health Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ritonavir / COVID-19 / COVID-19 Drug Treatment Limits: Adult / Humans / Male Language: En Journal: J Infect Public Health / J. infect. public health / Journal infection and public health Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2024 Document type: Article Affiliation country: Country of publication: